Related Experiment Videos
Lysozyme and IgA values in patients with atopic dermatitis
1Department of Dermatology, University of Tromsø, Norway.
Acta Dermato-Venereologica
|January 1, 1990
Summary
Patients with atopic dermatitis show lower levels of salivary lysozyme and immunoglobulin A (IgA). These immune markers in serum, however, remained comparable to healthy individuals, suggesting localized immune changes in the saliva.
Area of Science:
- Immunology
- Dermatology
- Biochemistry
Background:
- Atopic dermatitis is a chronic inflammatory skin condition.
- Salivary immune factors may play a role in atopic dermatitis pathogenesis.
- Lysozyme and immunoglobulin A (IgA) are key components of innate and adaptive immunity.
Purpose of the Study:
- To investigate salivary lysozyme and IgA levels in patients with atopic dermatitis.
- To compare these levels with those in healthy controls.
- To assess potential correlations between salivary immune markers and atopic dermatitis.
Main Methods:
- Study included ten patients diagnosed with atopic dermatitis and a control group.
- Saliva and serum samples were collected from all participants.
- Lysozyme activity and IgA concentrations were measured in both saliva and serum.
Main Results:
- Significantly lower lysozyme levels were observed in the saliva of atopic dermatitis patients compared to controls.
- Salivary IgA concentrations were also significantly reduced in patients with atopic dermatitis.
- No significant differences in lysozyme activity or IgA levels were found in the serum of patients and controls.
Conclusions:
- Atopic dermatitis is associated with reduced levels of key immune proteins in saliva.
- These findings suggest a localized deficit in salivary innate and adaptive immune components in atopic dermatitis.
- Further research is warranted to explore the functional implications of these salivary changes in atopic dermatitis.